Evolent Health (EVH) Enterprise Value (2015 - 2026)

Evolent Health has reported Enterprise Value for 12 years, with the latest figure at $471.3 million in Q2 2026.

• On a quarterly basis, Enterprise Value fell 58.84% year-over-year to $471.3 million in Q2 2026; TTM through Jun 2026 was $471.3 million, a 58.84% decrease from a year earlier, with the FY2025 full-year figure at $265.9 million, down 76.54% from the prior year.
• Enterprise Value was $471.3 million for Q2 2026 at Evolent Health, up from $87.7 million in the prior quarter.
• The five-year high for Enterprise Value was $3.6 billion in Q4 2023, with the low at $87.7 million in Q1 2026.
• Average Enterprise Value over 5 years is $2.1 billion, with a median of $2.6 billion recorded in 2022.
• The sharpest annual moves came in 2022 and 2026: Enterprise Value surged 85.63% in 2022, then plunged 89.48% in 2026.
• Over 5 years, Enterprise Value stood at $2.9 billion in 2022, then climbed by 23.63% to $3.6 billion in 2023, then sank by 68.43% to $1.1 billion in 2024, then slumped by 76.54% to $265.9 million in 2025, then jumped by 77.28% to $471.3 million in 2026.
• The last three Enterprise Value figures came in at $471.3 million (Q2 2026), $87.7 million (Q1 2026), and $265.9 million (Q4 2025), per Business Quant data.